Pharmaceutical companies invest in the discovery, development, manufacture and distribution of new drugs and therapies for the treatment of diseases.
The PRISM Emerging Pharma Index tracks small and micro-cap stocks that are contributing to driving innovation to improve healthcare for all.
| PRISM Emerging Pharmaceuticals IndexInception Date of 1/2/2024 at $100.00 | % Change (Daily) | Current Index Value | % Change (Inception) | |||||
|---|---|---|---|---|---|---|---|---|
| 0.7% | $161.80 | 61.8% | ||||||
| Index Components | Ticker | Current Price | % Daily Change | Volume (1,000s) | Average Volume (1,000s) | Market Cap (Millions) | 1/2/2024 Price | % Change Since Inception 1/2/2024 |
| TFF Pharmaceuticals, Inc. | TFFP | $0.07 | -60.049% | 11,020 | 1,678 | $0 | $6.91 | -99.1% |
| IO Biotech, Inc. | IOBT | $0.94 | 3.297% | 293 | 357 | $62 | $1.91 | -50.8% |
| OKYO Pharma Limited | OKYO | $1.07 | 1.905% | 6 | 57 | $36 | $1.94 | -44.8% |
| Kala Pharmaceuticals, Inc. | KALA | $6.94 | 9.558% | 50 | 26 | $32 | $6.95 | -0.2% |
| Lipella Pharmaceuticals Inc. | LIPO | $3.32 | 7.097% | 168 | 190 | $4 | $0.94 | 252.9% |
| Leap Therapeutics, Inc. | LPTX | $2.98 | 2.406% | 112 | 364 | $114 | $4.67 | -36.2% |
| Quoin Pharmaceuticals, Ltd. | QNRX | $0.56 | 11.577% | 379 | 3,332 | $3 | $4.84 | -88.4% |
| Oramed Pharmaceuticals Inc. | ORMP | $2.36 | -0.84% | 119 | 137 | $95 | $2.45 | -3.7% |
| ESSA Pharma Inc. | EPIX | $1.61 | 0% | 227 | 915 | $71 | $6.45 | -75.0% |
| Fennec Pharmaceuticals Inc. | FENC | $6.37 | 2.908% | 95 | 120 | $175 | $11.12 | -42.7% |
| Cumberland Pharmaceuticals Inc. | CPIX | $2.35 | -6.375% | 157 | 1,837 | $33 | $1.85 | 27.4% |
| Lumos Pharma, Inc. | LUMO | $4.34 | 0% | 391 | 101 | $38 | $3.22 | 34.8% |
| Merrimack Pharmaceuticals, Inc. | MACK | $15.15 | 0.099% | 923 | 183 | $224 | $13.31 | 13.8% |
| CorMedix Inc. | CRMD | $8.50 | 2.041% | 397 | 1,168 | $516 | $3.77 | 125.5% |
| Atea Pharmaceuticals, Inc. | AVIR | $3.29 | 1.231% | 332 | 271 | $278 | $3.21 | 2.5% |
| Tonix Pharmaceuticals Holding Corp. | TNXP | $0.37 | -3.971% | 77,095 | 97,552 | $69 | $0.42 | -11.5% |
| Armata Pharmaceuticals, Inc. | ARMP | $2.02 | -0.985% | 7 | 9 | $73 | $3.10 | -34.8% |
| Galmed Pharmaceuticals Ltd. | GLMD | $3.12 | 1.629% | 47 | 99 | $5 | $0.44 | 609.6% |
| Syros Pharmaceuticals, Inc. | SYRS | $0.22 | 6.407% | 1,269 | 8,731 | $6 | $7.84 | -97.2% |
| Hepion Pharmaceuticals, Inc. | HEPA | $0.50 | 0.202% | 27 | 44 | $3 | $3.15 | -84.3% |
| Athira Pharma, Inc. | ATHA | $0.54 | -0.646% | 587 | 4,826 | $21 | $2.89 | -81.4% |
| Actinium Pharmaceuticals, Inc. | ATNM | $1.29 | 5.738% | 296 | 300 | $40 | $5.32 | -75.8% |
| Rigel Pharmaceuticals, Inc. | RIGL | $17.26 | 4.988% | 247 | 231 | $304 | $1.46 | 1,082.2% |
| Biodexa Pharmaceuticals Plc | BDRX | $4.70 | 10.07% | 15 | 288 | $1,092 | $2.69 | 74.7% |
| Moleculin Biotech, Inc. | MBRX | $1.77 | -2.747% | 47 | 49 | $6 | $13.86 | -87.2% |
| Candel Therapeutics, Inc. | CADL | $9.17 | 4.205% | 2,070 | 3,351 | $408 | $1.45 | 532.4% |
| PharmaTher Holdings Ltd. | PHRRF | $0.15 | -6.25% | 51 | 359 | $13 | $0.25 | -40.0% |
| Corvus Pharmaceuticals, Inc. | CRVS | $5.29 | 7.959% | 1,207 | 1,110 | $340 | $1.76 | 200.6% |
| Trevi Therapeutics, Inc. | TRVI | $4.21 | 5.25% | 542 | 1,698 | $376 | $1.30 | 223.8% |
| Galectin Therapeutics Inc. | GALT | $0.87 | 3.509% | 1,031 | 514 | $54 | $1.74 | -50.0% |
| MannKind Corporation | MNKD | $6.89 | 2.226% | 2,208 | 2,623 | $1,900 | $3.92 | 75.8% |
| Applied Therapeutics, Inc. | APLT | $0.89 | 4.11% | 7,405 | 5,208 | $103 | $3.64 | -75.6% |
| Rockwell Medical, Inc. | RMTI | $2.16 | 0.465% | 346 | 737 | $70 | $1.86 | 16.1% |
| Alpha Teknova, Inc. | TKNO | $8.97 | 4.302% | 323 | 244 | $478 | $3.80 | 136.1% |
| Opus Genetics, Inc. | IRD | $1.08 | 3.846% | 575 | 193 | $34 | $3.07 | -64.8% |
| Adial Pharmaceuticals, Inc. | ADIL | $1.05 | 0% | 60 | 175 | $7 | $1.75 | -40.0% |
